WUXI Financial Statements From 2010 to 2024
| 1FW1 Stock | EUR 4.18 0.08 1.95% |
Check WUXI BIOLOGICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WUXI BIOLOGICS's main balance sheet or income statement drivers, such as , as well as many indicators such as . WUXI financial statements analysis is a perfect complement when working with WUXI BIOLOGICS Valuation or Volatility modules.
WUXI |
WUXI BIOLOGICS UNSPADR2 Company Shares Outstanding Analysis
WUXI BIOLOGICS's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current WUXI BIOLOGICS Shares Outstanding | 2.11 B |
Most of WUXI BIOLOGICS's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WUXI BIOLOGICS UNSPADR2 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, WUXI BIOLOGICS UNSPADR2 has 2.11 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The shares outstanding for all Germany stocks is significantly lower than that of the firm.
WUXI BIOLOGICS UNSPADR2 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WUXI BIOLOGICS's current stock value. Our valuation model uses many indicators to compare WUXI BIOLOGICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WUXI BIOLOGICS competition to find correlations between indicators driving WUXI BIOLOGICS's intrinsic value. More Info.WUXI BIOLOGICS UNSPADR2 is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for WUXI BIOLOGICS UNSPADR2 is roughly 2.23 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WUXI BIOLOGICS's earnings, one of the primary drivers of an investment's value.About WUXI BIOLOGICS Financial Statements
WUXI BIOLOGICS stakeholders use historical fundamental indicators, such as WUXI BIOLOGICS's revenue or net income, to determine how well the company is positioned to perform in the future. Although WUXI BIOLOGICS investors may analyze each financial statement separately, they are all interrelated. For example, changes in WUXI BIOLOGICS's assets and liabilities are reflected in the revenues and expenses on WUXI BIOLOGICS's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in WUXI BIOLOGICS UNSPADR2. Please read more on our technical analysis and fundamental analysis pages.
WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. WuXi Biologics Inc. is a subsidiary of WuXi Biologics Holdings Limited. WUXI BIOLOGICS is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in WUXI Stock
WUXI BIOLOGICS financial ratios help investors to determine whether WUXI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WUXI with respect to the benefits of owning WUXI BIOLOGICS security.